Building detailed maps of human cells to help AI explain how genes affect health

Bridge2AI: Cell Maps for AI (CM4AI) Data Generation Project

NIH-funded research University of California, San Diego · NIH-11376383

Researchers are creating high-resolution maps of human cells and tissues to help AI better explain how genetic differences relate to disease for people with diverse conditions.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego NIH-funded
Lab location1 site (La Jolla, United States)
Project IDNIH-11376383 on NIH RePORTER

What this research studies

If you take part, the project would collect tissue and cell samples and use three main approaches—protein mass spectrometry, detailed cellular imaging, and CRISPR-based genetic changes—to map cell structure and function. The team plans to include samples from different ages, backgrounds, and disease states so the maps reflect real patient diversity. Those maps will be combined with AI tools so predictions from genes to symptoms are more visible and easier to understand, and all data will be shared under open, FAIR principles. The project also focuses on the ethics of using these maps in genomic medicine and on training new researchers in biomachine learning.

Who could benefit from this research

Good fit: Ideal participants would be people who can provide tissue or blood samples—including patients with conditions of interest and healthy volunteers from diverse backgrounds—at participating collection sites.

Not a fit: People looking for immediate treatment from the project are unlikely to receive direct clinical benefit, especially if they do not provide samples or are not enrolled at collection sites.

Why it matters

Potential benefit: If successful, these maps could make AI-based genetic tests more explainable and help guide more accurate diagnoses and targeted treatments.

How similar studies have performed: The effort builds on successful initiatives like the Human Cell Atlas and proven CRISPR and proteomics methods, but combining them to produce AI-interpretable cell maps is a newer and ambitious direction.

Where this research is happening

La Jolla, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.